Amyloid‑β guided responsive theranostic fluorescent probe for imaging of endogenous hydrogen peroxide in Alzheimer disease
Sensors and Actuators B: Chemical, ISSN: 0925-4005, Vol: 406, Page: 135452
2024
- 4Citations
- 2Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Most Recent News
New Findings on Alzheimer Disease Described by Investigators at Hong Kong Baptist University (Amyloid-b Guided Responsive Theranostic Fluorescent Probe for Imaging of Endogenous Hydrogen Peroxide In Alzheimer Disease)
2024 MAY 02 (NewsRx) -- By a News Reporter-Staff News Editor at Daily Hong Kong Report -- Investigators publish new report on Neurodegenerative Diseases and
Article Description
Alzheimer disease (AD) is an irreversible and incurable neurodegenerative disorder. Amyloid- β (A β ), the pathological hallmarks of AD, is known to induce oxidative stress due to the overproduction of reactive oxygen species (ROS) such as hydrogen peroxide (H 2 O 2 ) leading to neurotoxicity and ultimately, neuronal death. Therefore, H 2 O 2 could be a reliable biomarker for more precise detection and diagnosis of AD. Herein, we report the development of highly sensitive and effective ratiometric A β -guided H 2 O 2 -responsive theranostic probes for sensing and tracking of endogenous H 2 O 2 in AD mouse models. Among the probes synthesized, HY3 was shown to possess superior multifunctional properties including low cytotoxicity and good biocompatibility, strong binding with A β and large A β binding-induced fluorescence enhancement, excellent H 2 O 2 specificity, superior stability, and of particular importance, rapid response, and high sensitivity toward H 2 O 2 in the presence of A β for selective imaging and monitoring of endogenous H 2 O 2 in real time in AD mouse model. Molecular docking revealed the difference in the binding motif and interactions of the probe HY3 and its H 2 O 2 -oxidized product, HY2 with A β fibrils giving rise to the difference of A β binding-induced fluorescence enhancement between them. Impressively, with the promotion of A β, HY3 was able to detect the endogenous H 2 O 2 level ratiometrically in AD cell model and differentiate the difference between the normal and AD cells. More importantly, the excellent BBB permeable and biocompatible HY3 probe enabled it to target the senile plaques and serve as an effective and highly sensitive ratiometric fluorescent probe to image and monitor endogenous H 2 O 2 level in vivo in different age groups of AD mice. Furthermore, the inhibitory function against A β aggregation of HY2 offers an additional benefit for the therapeutic use of this versatile probe. Our results suggested that H 2 O 2 could be a useful and reliable biomarker for AD and HY3 is a highly promising and effective tool in the detection of A β -induced H 2 O 2 level in vivo for more precise diagnosis of AD as well as can serve as a potential pro-drug to treat AD.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0925400524001813; http://dx.doi.org/10.1016/j.snb.2024.135452; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85184816780&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S0925400524001813; https://dx.doi.org/10.1016/j.snb.2024.135452
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know